Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration
16 affiliations
- 1Department of Urology, Veterans Health Service Medical Center, Seoul, Korea .
- 2Department of Urology, Ewha Womans University Urology Institute, Ewha Womans University Mokdong Hospital, Seoul, Korea .
- 3Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea .
- 4Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea .
- 5Department of Urology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea .
- 6Department of Urology, Keimyung University Dongsan Hospital, Daegu, Korea .
- 7Department of Urology, Hanyang University College of Medicine, Seoul, Korea .
- 8Department of Urology, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea .
- 9Department of Urology, Urological Cancer Center, National Cancer Center, Goyang, Korea .
- 10Department of Urology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea .
- 11Department of Urology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea .
- 12Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea .
- 13Department of Urology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea .
- 14Department of Urology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea .
- 15Division of Health Administration, College of Health Science, Yonsei University, Wonju, Korea .
- 16Institute for Planetary Health, Yonsei University, Wonju, Korea .
Abstract
Purpose: Prostate cancer has become the most common male malignancy in Korea, yet prostate-specific antigen (PSA)–based screening remains excluded from the national cancer screening program and is performed predominantly on an opportunistic basis. Long-term randomized evidence comparing organized PSA-based screening with opportunistic testing is complex and variably interpreted. This study aimed to assess expert consensus on whether an organized early-detection framework offers advantages over the current opportunistic model in Korea.
Materials and Methods: A structured, three-round Delphi study was conducted among 15 Korean urologists with expertise in prostate cancer management and PSA-based early detection. Statements were informed by international guidelines, long-term randomized trial evidence, and Korean epidemiologic data, covering conceptual justification and screening parameters. Consensus was predefined using Likert-scale agreement/disagreement thresholds and a within-group agreement index (rwg ≥0.80).
Results: All panelists completed all three rounds. Consensus was achieved that PSA-based early detection provides a net population-level benefit; that organized, invitation-based screening is preferable to opportunistic testing; and that active surveillance should be the default for low-risk disease. Initiation at age 55 reached stable consensus, whereas discontinuation at age 80 reached consensus only in the final round, indicating an upper bound within an individualized 75- to 80-year stopping range. No fixed screening interval achieved sustained agreement, supporting risk-adapted approaches.
Conclusions: This Delphi study supports the feasibility of an organized, risk-adapted PSA-based early detection framework in Korea. Subsequent multidisciplinary input from preventive medicine, primary care, health economics, and patient perspectives is required before policy implementation.
Related
- Biomarker use in the prostate cancer screening pathway: Maps of the evidence
- Federated learning for privacy-preserving opportunistic screening of lumbar-spine DXA-defined osteoporotic-level bone mineral density using chest radiographs: A multi-center independent validation study
- Histopathological Spectrum and Yield of Advanced Neoplasia in Opportunistic Colonoscopy Without Organised Screening: A Single-Centre Cross-Sectional Study from Western Romania
- CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging
- Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models.
BibTeX
@article{ryu2026prostate,
title = {{Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration}},
author = {Jae Hyun Ryu and Young Hwii Ko and Jungyo Suh and Hyunho Han and Woojin Bang and Byung Hoon Kim and Sung Yul Park and Jae-Seung Chung and Jae Young Joung and Seok-Soo Byun and Sung-Woo Park and Byong Chang Jeong and Kwan Joong Joo and Young Goo Lee and Min-Hee Heo and Jin-Won Noh and Seong Il Seo},
journal = {Investigative and Clinical Urology},
year = {2026},
month = oct,
doi = {10.4111/icu.20260128},
url = {https://doi.org/10.4111/icu.20260128},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Prostate cancer screening beyond opportunistic testing: A Delphi consensus and evidence integration
AU - Jae Hyun Ryu
AU - Young Hwii Ko
AU - Jungyo Suh
AU - Hyunho Han
AU - Woojin Bang
AU - Byung Hoon Kim
AU - Sung Yul Park
AU - Jae-Seung Chung
AU - Jae Young Joung
AU - Seok-Soo Byun
AU - Sung-Woo Park
AU - Byong Chang Jeong
AU - Kwan Joong Joo
AU - Young Goo Lee
AU - Min-Hee Heo
AU - Jin-Won Noh
AU - Seong Il Seo
PY - 2026
DA - 2026/10/21
JO - Investigative and Clinical Urology
DO - 10.4111/icu.20260128
UR - https://doi.org/10.4111/icu.20260128
AB - Purpose: Prostate cancer has become the most common male malignancy in Korea, yet prostate-specific antigen (PSA)–based screening remains excluded from the national cancer screening program and is performed predominantly on an opportunistic basis. Long-term randomized evidence comparing organized PSA-based screening with opportunistic testing is complex and variably interpreted. This study aimed to assess expert consensus on whether an organized early-detection framework offers advantages over the current opportunistic model in Korea. Materials and Methods: A structured, three-round Delphi study was conducted among 15 Korean urologists with expertise in prostate cancer management and PSA-based early detection. Statements were informed by international guidelines, long-term randomized trial evidence, and Korean epidemiologic data, covering conceptual justification and screening parameters. Consensus was predefined using Likert-scale agreement/disagreement thresholds and a within-group agreement index (rwg ≥0.80). Results: All panelists completed all three rounds. Consensus was achieved that PSA-based early detection provides a net population-level benefit; that organized, invitation-based screening is preferable to opportunistic testing; and that active surveillance should be the default for low-risk disease. Initiation at age 55 reached stable consensus, whereas discontinuation at age 80 reached consensus only in the final round, indicating an upper bound within an individualized 75- to 80-year stopping range. No fixed screening interval achieved sustained agreement, supporting risk-adapted approaches. Conclusions: This Delphi study supports the feasibility of an organized, risk-adapted PSA-based early detection framework in Korea. Subsequent multidisciplinary input from preventive medicine, primary care, health economics, and patient perspectives is required before policy implementation.
SN - 2466-0493
SN - 2466-054X
ER -